ProCE Banner Activity

A Global Perspective: PARP Inhibitors in the Treatment of Metastatic Breast Cancer

Slideset Download
Download this slideset from a panel of international experts on current evidence for PARP inhibitors for patients with MBC.

Released: November 24, 2020

Expiration: November 23, 2021

No longer available for credit.

Share

Faculty

Pierfranco Conte

Pierfranco Conte, MD

Professor
DiSCOG
University of Padua
Padua, Italy
Director
U.O.C. Oncology 2
Istituto Oncologico Veneto, IOV - IRCSS
Padova, Italy

Véronique Diéras

Véronique Diéras, MD

Head, Breast Group
Medical Oncology Department
Centre Eugene Marquis UNICANCER
Rennes, France

Mark E. Robson

Mark E. Robson, MD

Chief, Breast Medicine Service
Attending Physician
Clinical Genetics and Breast Medicine Services
Department of Medicine
Memorial Sloan Kettering Cancer Center
New York, New York

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

AstraZeneca

Faculty Disclosure

Primary Author

Pierfranco Conte, MD

Professor
DiSCOG
University of Padua
Padua, Italy
Director
U.O.C. Oncology 2
Istituto Oncologico Veneto, IOV - IRCSS
Padova, Italy

Véronique Diéras, MD

Head, Breast Group
Medical Oncology Department
Centre Eugene Marquis UNICANCER
Rennes, France

Mark E. Robson, MD

Chief, Breast Medicine Service
Attending Physician
Clinical Genetics and Breast Medicine Services
Department of Medicine
Memorial Sloan Kettering Cancer Center
New York, New York